<DOC>
	<DOCNO>NCT01511887</DOCNO>
	<brief_summary>The aim current study evaluate efficacy safety oral Ibuprofen term 20-28 day old newborn refer Bandarabbas child ' hospital 2011 .</brief_summary>
	<brief_title>Safety Efficacy Ibuprofen Term Newborns With Patent Ductus Arteriosus ( PDA )</brief_title>
	<detailed_description>Patent Ductus Arteriosus ( PDA ) account 10 % Congenital Heart Disease . Surgical treatment PDA associate high rate complication pharmacologic treatment . Efficacy Ibuprofen show preterm low birth weight newborn PDA . Studies term neonate first day birth rare . The aim current study evaluate efficacy safety oral Ibuprofen term 20-28 day old newborn refer Bandarabbas child ' hospital 2011 .</detailed_description>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Term newborn ( 37 week gestation ) Age 2028 day confirm diagnosis PDA echocardiography pediatric cardiologist Asphyxia Hemorrhage Platelet count &lt; 150000 renal gastrointestinal malformation associate congenital heart disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Days</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Patent Ductus Arteriosus</keyword>
	<keyword>PDA</keyword>
	<keyword>Term newborn</keyword>
	<keyword>Ibuprofen</keyword>
</DOC>